PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway

Authors: Yuanzhen Ma, Zhiyu Fang, Hongning Zhang, Yijun Qi, Yuke Mao, Junfang Zheng

Source: Cell Death and Disease, Vol 15, Iss 3, Pp 1-14 (2024)

Subject Terms: Cytology, QH573-671

File Description: electronic resource

Relation: https://doaj.org/toc/2041-4889

Access URL: https://doaj.org/article/34642f5ad4f9469085c41078cc86ff04

Inhibitor tolerance and bioethanol fermentability of levoglucosan-utilizing Escherichia coli were enhanced by overexpression of stress-responsive gene ycfR: The proteomics-guided metabolic engineering

Authors: Dongdong Chang, Zia Ul Islam, Junfang Zheng, Jie Zhao, Xiaoyong Cui, Zhisheng Yu

Source: Synthetic and Systems Biotechnology, Vol 6, Iss 4, Pp 384-395 (2021)

Subject Terms: Lignocellulosic biomass, Levoglucosan, Inhibitor, Proteomics, Gene overexpression, Bioethanol, Biotechnology, TP248.13-248.65, Biology (General), QH301-705.5

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2405805X21000715; https://doaj.org/toc/2405-805X

Access URL: https://doaj.org/article/6051f382abe5493486e6bc8c9ec174cc

GLUD1 suppresses renal tumorigenesis and development via inhibiting PI3K/Akt/mTOR pathway

Authors: Lei Wang, Zhiyu Fang, Peixiang Gao, Junfang Zheng

Source: Frontiers in Oncology, Vol 12 (2022)

Subject Terms: GLUD1, renal cell carcinoma, prognosis, methylation, PI3K/Akt/mTOR, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.975517/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/a76199cf0d864bba826050cd93987e68

SDHB Suppresses the Tumorigenesis and Development of ccRCC by Inhibiting Glycolysis

Authors: Zhiyu Fang, Qiang Sun, Huihui Yang, Junfang Zheng

Source: Frontiers in Oncology, Vol 11 (2021)

Subject Terms: SDHB, renal cell carcinoma, prognosis, methylation, glycolysis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2021.639408/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/bbe8831158e348e1a405177e359edd00

Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma

Authors: Junfang Zheng, Lei Wang, Zhiqiang Peng, Ying Yang, Duiping Feng, Junqi He

Source: EBioMedicine, Vol 15, Iss C, Pp 62-72 (2017)

Subject Terms: Renal cancer, Proteomics, Prognostic markers, PDZ, CAP70, NHERF3, CLAMP, Medicine, Medicine (General), R5-920

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352396416305825; https://doaj.org/toc/2352-3964

Access URL: https://doaj.org/article/2a50cfd63b014142ba1957790b00d76b

NDUFA4L2 is associated with clear cell renal cell carcinoma malignancy and is regulated by ELK1

Authors: Lei Wang, Zhiqiang Peng, Kaizhen Wang, Yijun Qi, Ying Yang, Yue Zhang, Xinyuan An, Shudong Luo, Junfang Zheng

Source: PeerJ, Vol 5, p e4065 (2017)

Subject Terms: NDUFA4L2, Clear cell renal cell carcinoma, Transcription factor, ELK1, Medicine, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://peerj.com/articles/4065.pdf; https://peerj.com/articles/4065/; https://doaj.org/toc/2167-8359

Access URL: https://doaj.org/article/788bc6344ebd44618ff3156b64f29ab0

NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling.

Authors: YAN WANG, ZHIQIANG PENG, RAN MENG, TAO TAO, QIQI WANG, CHUNJUAN ZHAO, HUA LIU, RAN SONG, JUNFANG ZHENG, QIONG QIN, JUNQI HE

Source: Oncology Reports; Jul2017, Vol. 38 Issue 1, p221-228, 8p

Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells.

Authors: DUIPING FENG, YING XIONG, ZHIQIANG PENG, QIANG MA, TAO TAO, HUA LIU, JIANFANG LIANG, ZHIGANG WEI, JUNFANG ZHENG, LEI WANG, HUI ZHANG

Source: Oncology Letters; Apr2017, Vol. 13 Issue 4, p2758-2764, 7p

Subject Terms: CHOLANGIOCARCINOMA, CANCER cell proliferation, CANCER immunology, PROMOTERS (Genetics), CLINICAL pathology, IMMUNOHISTOCHEMISTRY

miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression.

Authors: QIANG MA, ZHIQIANG PENG, LEI WANG, YANMING LI, KAIZHEN WANG, JUNFANG ZHENG, ZHIYONG LIANG, TONGHUA LIU

Source: International Journal of Oncology; Dec2016, Vol. 49 Issue 6, p2589-2599, 11p

EBP50 interacts with EGFR and regulates EGFR signaling to affect the prognosis of cervical cancer patients.

Authors: ZHIQIANG PENG, QIQI WANG, YUE ZHANG, JUNQI HE, JUNFANG ZHENG

Source: International Journal of Oncology; Oct2016, Vol. 49 Issue 4, p1737-1745, 9p

NHERF1 regulates actin cytoskeleton organization through modulation of α-actinin-4 stability.

Authors: Licui Sun¹, Junfang Zheng^1,2, Qiqi Wang¹, Ran Song^1,2, Hua Liu^1,2, Ran Meng¹, Tao Tao¹, Yang Si^1,2, Wenguo Jiang^2,3, Junqi He^1,2,4 jq_he@ccmu.edu.cn

Source: FASEB Journal. Feb2016, Vol. 30 Issue 2, p578-589. 12p.

Subject Terms: *CYTOSKELETON, *ACTININ, *CHEMICAL stability, *MOLECULAR models, *PROTEIN expression

Targeting of NHERF1 through RNA interference inhibits the proliferation and migration of metastatic prostate cancer cells.

Authors: QIANG MA, YANNA JIAO, YUMEI HAO, SHANSHAN YAN, NENAN LYU, HONGLIN GAO, DEGUAN LI, QIANG LIU, JUNFANG ZHENG, NALING SONG

Source: Oncology Letters; Feb2016, Vol. 11 Issue 2, p1149-1154, 6p

Subject Terms: SODIUM-hydrogen antiporter regulatory factor, PROSTATE cancer, CANCER cell culture, CANCER cell proliferation, CANCER cell migration, BCL-2 proteins, WESTERN immunoblotting

Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN.

Authors: JUNFANG ZHENG, YUANPING DAI, ZHIYU YANG, LONGYAN YANG, ZHIQIANG PENG, RAN MENG, YING XIONG, JUNQI HE

Source: Oncology Reports; 2016, Vol. 35 Issue 1, p530-537, 8p

The β1-adrenergic receptor mediates extracellular signal-regulated kinase activation via Gαs.

Authors: Junfang Zheng¹, Hui Shen¹, Ying Xiong¹, Xiaomei Yang¹, Junqi He¹ jq_he@ccmu.edu.cn

Source: Amino Acids. Jan2010, Vol. 38 Issue 1, p75-84. 10p. 1 Diagram, 4 Graphs.

Subject Terms: *ADRENERGIC receptors, *PROTEIN kinases, *EPIDERMAL growth factor, *MITOGEN-activated protein kinases, *DRUG receptors

Study on Thermal Stability and High Temperature Gas Production of Silicate Concrete.

Authors: Liang Li, Jijun Zhang, Junfang Zheng, Dongliang Zhang, Xiaoning Yuan, Xianhe Mao, Ying Xu

Source: IOP Conference Series: Materials Science & Engineering; July2018, Vol. 382 Issue 2, p1-1, 1p